Prosight Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.2M Sell
238,088
-137,521
-37% -$16.2M 5.27% 6
2026
Q2
$40M Buy
+375,609
New +$45.5M 6.9% 6
2023
Q2
– Sell
-26,359
Closed -$449K – 42
2023
Q1
$449K Buy
+26,359
New +$512K 0.21% 34

Other funds holding INSM

Prosight Management's INSM Position: Q3 2026 in Review

Prosight Management reduced its Insmed (INSM) stake by 37% in Q3 2026, selling an estimated $16.2M and leaving 238,088 shares worth $27.2M. The position accounts for 5.27% of the portfolio, ranked #6.

Prosight Management first reported a position in INSM in Q1 2023 and has held it in 3 quarters since. The position peaked at $40M in Q2 2026. 704 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Prosight Management held 238,088 shares of Insmed worth $27.2M as of Q3 2026.
  • Prosight Management sold 137,521 Insmed shares in Q3 2026, an estimated $16.2M.
  • Insmed made up 5.27% of Prosight Management's portfolio in Q3 2026, its #6 holding.
  • Prosight Management first reported a position in Insmed in Q1 2023 and has held it in 3 quarters since.
  • Prosight Management's Insmed position peaked at $40M in Q2 2026.
  • 704 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Prosight Management's 13F filing for Q3 2026, filed 13 Nov 2026.